AstraZeneca Investor Conference Presentation Deck

AstraZeneca: a sustainable, long-term growth opportunity Multiple organic levers drive momentum and sustain attractive growth profile 14 CAGR = compound annual growth rate. 1 Industry-leading execution 2 3 Strong track-record across key therapy areas Late-stage pipeline success Robust breadth and depth of Phase II and Phase III programmes including several high potential medicines Investment in early-stage Advancing key assets with blockbuster-potential and investing in new platforms and technology to unlock the next waves of growth Committed to delivering Low double-digit revenue CAGR through 2025 AND industry-leading growth 2025+ B

View entire presentation